The mean percentage of Treg cells (CD4+CD25highFoxP3+) within CD4+ cells was much higher in the PBMCs of multiple myeloma patients than in healthy subjects, and decreased substantially after the first cycle with lenalidomide and glucocorticoids, even if the decrease was not significant. The gene discussed is CD4; the disease is plasma cell myeloma.